Abstract:The mechanism of neuronal loss in Alzheimer's disease (AD) remains unknown, although circumstantial evidence of apoptosis in postmortem brain tissues has supported the hypothesis that an apoptotic mechanism plays a role in the neurodegeneration in AD. Mutations in presenilins 1 and 2 (PS1/2) are responsible for the majority of familial AD. These proteins are localized predominantly in the endoplasmic reticulum (ER) and Golgi apparatus, and form heteromeric protein complexes to participate in several functions. Previous studies have shown that PS1/2 are involved in the regulation of apoptotic cell death, although the molecular basis is still unresolved. The aim of this study is to clarify the molecular basis by which PS1/2 regulate apoptosis. We also address a question how presenilin mutations modify the regulatory activity. We performed yeast 2–hybrid screen, co–immunoprecipitation assay, glycerol velocity gradient centrifugation and subcellular fractionation with iodixanol gradient, using HEK293 cells, PS1/2–knockout mouse fibroblasts and I213T–PS1–knockin mouse brains. PS1/2 interacted with FKBP38 that is an immunophilin family member residing in the mitochondrial membrane and inhibits apoptosis by targeting and anchoring anti–apoptotic Bcl–2 to the mitochondria. PS1/2 and FKBP38 formed macromolecular complexes together with Bcl–2. This complex formation promoted the degradation of FKBP38 and Bcl–2, and sequestered these proteins in the ER/Golgi compartments, thereby inhibiting FKBP38–mediated mitochondrial targeting of Bcl–2. Thus, full–length PS1/2 increased the susceptibility to apoptosis by antagonizing the anti–apoptotic function of FKBP38. In contrast, C–terminal fragments of caspase–processed PS1/2 redistributed Bcl–2 to the mitochondria by abrogating the activity of full–length PS1/2, resulting in a dominant–negative anti–apoptotic effect. In cultured cells and mutant PS1–knockin mouse brains, familial AD–linked PS1/2 mutants enhanced the pro–apoptotic activity by causing a more efficient reduction in mitochondrial Bcl–2 than wild–type PS1/2. We demonstrated that PS1/2 regulate the susceptibility to apoptosis by interacting with FKBP38. These results suggest a novel molecular mechanism for the regulation of mitochondria–mediated apoptosis by competition between PS1/2 and FKBP38 for subcellular targeting of Bcl–2. Furthermore, familial AD–linked mutations in PS1/2 could lower the threshold for activation of mitochondria–mediated apoptosis pathways in neurons of individuals with familial AD.

Random Mutagenesis of Presenilin-1 Identifies Novel Mutants Exclusively Generating Long Amyloid β-Peptides

Presenilin 1 Mutations Linked to Familial Alzheimer's Disease Increase the Intracellular Levels of Amyloid Β‐protein 1–42 and Its N‐Terminally Truncated Variant(s) Which Are Generated at Distinct Sites

FAD-linked Mutations in Presenilin 1 Alter the Length of Abeta Peptides Derived from Betaapp Transmembrane Domain Mutants.

Familial Alzheimer Disease-linked Presenilin 1 Variants Enhance Production of Both Aβ1–40 and Aβ1–42 Peptides That Are Only Partially Sensitive to a Potent Aspartyl Protease Transition State Inhibitor of “Γ-Secretase”

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio in Vitro and in Vivo

A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of Γ-Secretase Activity

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD

The E280A Presenilin 1 Alzheimer Mutation Produces Increased Aβ42 Deposition and Severe Cerebellar Pathology

Pen2 And Presenilin-1 Modulate The Dynamic Equilibrium Of Presenilin-1 And Presenilin-2 Gamma-Secretase Complexes

Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase

Mutation Analysis of Presenilin-1 Gene in Alzheimer' S Disease Patients and the Effects of Its Mutation on Expression of Presenilin-1 and Amyloid Precursor Protein

Presenilin 1 Regulates Pharmacologically Distinct Gamma -Secretase Activities. Implications for the Role of Presenilin in Gamma -Secretase Cleavage.

Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production

APP Substitutions V715F and L720P Alter PS1 Conformation and Differentially Affect Abeta and AICD Generation.

Presenilin-1 Mutation L271V Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No Neuritic Dystrophy

P3-402: Pathogenic Mutations of Presenilins Enhance Pro-Apoptotic Activity by Reducing Mitochondrial Bcl-2

Pathological and Physiological Functions of Presenilins

Presenilin-1, mutated in familial Alzheimer's disease, maintains genome stability via a γ-secretase dependent way

Potent amyloidogenicity and pathogenicity of Aβ43

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Substitution of a Glycogen Synthase Kinase-3β Phosphorylation Site in Presenilin 1 Separates Presenilin Function from β-Catenin Signaling*